Lilly to sell obesity drugs directly on Hims & Hers site

1

By Michael Erman Nov 6 (Reuters) – Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform, sending the telehealth

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)